Skip to main content
. Author manuscript; available in PMC: 2015 Nov 25.
Published in final edited form as: Urology. 2015 May;85(5):1111–1116. doi: 10.1016/j.urology.2015.02.014

Figure 1.

Figure 1

Multivariate-adjusted hazard ratio of prostate cancer mortality for screening prostate-specific antigen concentration overall (A), by baseline age (B), and body mass index (C). BMI, body mass index; HR, hazard ratio; PSA, prostate-specific antigen.